|
Imiquimod Clinical Trials
3 actively recruiting trials across 2 locations
No change since May 2026
Also known as: Aldara, R 837, S 26308, Zyclara
Pipeline
Early 1: 1Phase 1: 1
Top Sponsors
- Northwestern University1
- M.D. Anderson Cancer Center1
- Catharina Ziekenhuis Eindhoven1
Indications
- Cancer3
- Stage IVB Colorectal Cancer AJCC v71
- Stage IVA Colorectal Cancer AJCC v71
- Metastatic Colorectal Adenocarcinoma1
- Stage IV Pancreatic Cancer AJCC v6 and v71
Other1 trial
Chicago, Illinois1 trial
Combining Topical Imiquimod With Local Radiotherapy for Treatment of Mycosis Fungoides
Northwestern University Department of Dermatology
Early 1
Houston, Texas1 trial
Personalized Peptide Vaccine in Treating Patients With Advanced Pancreatic Cancer or Colorectal Cancer
M D Anderson Cancer Center
Phase 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.